Fuji Pharma Co Ltd
TSE:4554
Fuji Pharma Co Ltd
TSE:4554
Price:
1 552 JPY
0.58%
Market Closed
Updated:
Apr 28, 2024
Fuji Pharma Co Ltd
Cash from Financing Activities
|
Fuji Pharma Co Ltd
Cash from Financing Activities Peer Comparison
Comparables:
4502
4568
4578
4519
4503
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Fuji Pharma Co Ltd
TSE:4554
|
Cash from Financing Activities
¥1.9B
|
CAGR 3-Years
62%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-6%
|
|
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Cash from Financing Activities
-¥302.8B
|
CAGR 3-Years
29%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
Cash from Financing Activities
-¥123.5B
|
CAGR 3-Years
4%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
Cash from Financing Activities
-¥60.3B
|
CAGR 3-Years
17%
|
CAGR 5-Years
8%
|
CAGR 10-Years
2%
|
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Cash from Financing Activities
-¥139.3B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-32%
|
CAGR 10-Years
-20%
|
|
|
Astellas Pharma Inc
TSE:4503
|
Cash from Financing Activities
¥478.6B
|
CAGR 3-Years
53%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Fuji Pharma Co Ltd's Cash from Financing Activities?
Cash from Financing Activities
1.9B
JPY
1.9B
JPY
Based on the financial report for Dec 31, 2023, Fuji Pharma Co Ltd's Cash from Financing Activities amounts to 1.9B JPY.
What is Fuji Pharma Co Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
-6%
-6%
Over the last year, the Cash from Financing Activities growth was -62%. The average annual Cash from Financing Activities growth rates for Fuji Pharma Co Ltd have been 62% over the past three years , and -6% over the past ten years .
You don't have any saved screeners yet
